Palisade Bio Inc Earnings

The next earnings date for Palisade Bio Inc has not yet been scheduled.

Analyst Estimates of Palisade Bio Inc Earnings

No Results.

Report Date	Estimated Earnings Per Share
No Results.

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Palisade Bio Inc Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
05/12/2025	Before Market	$-0.47	41.98%
03/25/2025	Before Market	$-0.69	65.27%
11/07/2024	After Market	$-2.32	30.63%
08/09/2024	Before Market	$-3.32	-13.31%
05/13/2024	After Market	$-4.59	4.38%
03/26/2024	After Market	$-6.45	-24.76%
11/09/2023	After Market	$-0.44	-12.82%
08/11/2023	Before Market	$-0.53	-17.78%
05/11/2023	After Market	$-0.54	25.00%
03/22/2023	After Market	$6.47	366.26%
11/14/2022	Before Market	$-4	0.00%
08/15/2022	Before Market	$-6	29.41%
05/13/2022	Before Market	$-13	7.14%
03/17/2022	After Market	$4	134.04%
11/15/2021	Before Market	$21	216.67%
08/23/2021	After Market	$-3.53	---
05/14/2021	After Market	$-4.39	---
03/22/2021	After Market	$-0.25	---
11/10/2020	After Market	$-4.39	---
08/13/2020	After Market	$-4.39	---
05/15/2020	After Market	$-4.39	---
03/27/2020	After Market	$-4.39	---
11/14/2019	After Market	$-4.39	---
08/14/2019	---	$-4.39	---
05/14/2019	---	$-0.22	---
03/22/2019	---	$-0.22	---
11/14/2018	---	$-0.12	---
08/15/2018	---	$-0.80	---
04/02/2018	Before Market	$-2.80	---
03/22/2018	---	$-0.18	---
11/08/2017	Before Market	$-0.18	---
08/08/2017	Before Market	$-2,160	50.68%
05/10/2017	Before Market	$-2,580	17.31%
03/23/2017	Before Market	$-4,200	-34.62%
11/08/2016	Before Market	$-3,900	-42.86%
08/11/2016	After Market	$-3,120	20.00%
05/09/2016	Before Market	$-5,460	-27.27%
03/14/2016	After Market	$-3,900	23.08%
11/09/2015	Before Market	$-15.60	7.69%
08/10/2015	Before Market	$-15.60	5.28%
05/08/2015	Before Market	$-15.60	0.00%
03/16/2015	Before Market	$-15.60	-20.00%
11/07/2014	Before Market	$-13	9.09%
08/08/2014	Before Market	$-20.80	-60.00%
05/12/2014	---	$-18.20	-16.67%
03/10/2014	---	$-10.40	33.33%
11/12/2013	---	$-23.40	-125.00%
08/09/2013	---	$-23.40	-100.00%
05/10/2013	---	$-10.40	11.11%
03/15/2013	---	$-7.80	50.00%
11/09/2012	---	$-10.40	0.00%
08/10/2012	---	$-7.80	40.00%
05/09/2012	---	$-55,795.73	---
03/29/2012	---	$-13	16.67%
11/09/2011	---	$-18.20	0.00%
08/10/2011	---	$-20.80	27.27%
05/10/2011	---	$-18.20	30.00%
03/16/2011	---	$-13	50.00%
11/16/2010	---	$-23.40	18.18%
08/17/2010	---	$-136,466.94	---
05/18/2010	---	$-205,435.99	---
11/17/2009	---	$-172,542.50	---
08/14/2009	---	$-110,534.44	---
05/18/2009	---	$29,729.21	---
11/14/2008	---	$-115,647.27	---
08/15/2008	---	$-107,769.91	---
05/15/2008	---	$-83,780.50	---
02/27/2008	---	$-105,299.98	---
11/14/2007	---	$-56,642.81	---

More About Palisade Bio Inc

Website

https://www.palisadebio.com

Country

USA

Full Time Employees

Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases. The company's lead therapeutic candidate is PALI-2108, a prodrug PDE4 inhibitor that is in phase 1a/b clinical trial for the treatment of ulcerative colitis, as well as under phase 1a clinical trial for the treatment of fibrostenotic crohn's disease. It has a research collaboration and license agreement with Giiant Pharma, Inc. for the development, manufacture, and commercialization of its compounds; a license agreement with the Regents of the University of California for sole purpose of maintaining the Newsoara Co-Development; and a co-development and distribution agreement with Newsoara Biopharma Co., Ltd. The company is headquartered in Carlsbad, California.

“Palisade Bio Inc Earnings” Can Refer to the Palisade Bio Inc Earnings Date

Some people say “Palisade Bio Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Palisade Bio Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Palisade Bio Inc Stock on the Earnings Date

If you own Palisade Bio Inc stock (PALI) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Palisade Bio Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Palisade Bio Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Palisade Bio Inc Earnings

You can contact us any time if you would like to ask questions about Palisade Bio Inc earnings or anything else related to the stock market.